Pembrolizumab in Combination With Salvage Chemotherapy for First-relapsed or Refractory Classical Hodgkin Lymphoma
Clinical trial NCT04838652 · RECRUITING
Trial details
- NCT number
- NCT04838652
- Sponsor
- University of Cologne
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-05
- Primary completion
- 2026-05-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.